文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹

微生物组在银屑病中的作用:从疾病描述到治疗选择

The role of the microbiome in psoriasis: moving from disease description to treatment selection?
PubMed 文献 · Br J Dermatol · 2018-03-06

本文综述皮肤微生物组在健康与慢性炎症性疾病中的变化,重点讨论银屑病。文章简述16S rRNA测序流程,分析微生物组与免疫系统交互机制及个体内交叉对话的可能临床意义,提出整合皮肤微生物组特征与疾病及药物反应内型有望推动个体化治疗。

要点

  • 皮肤微生物组受部位、个体、疾病和遗传因素影响,程度尚不明确。
  • 16S rRNA测序提升了对皮肤微生物多样性的认识。
  • 整合微生物组特征与疾病内型可能指导银屑病个体化治疗。

核心结论

  • 在个体化医疗时代,整合皮肤微生物组特征与全面的疾病及药物反应内型将开启慢性多系统炎症性疾病临床管理的新方法。

研究设计与样本

  • 本文为综述,简述16S核糖体RNA测序流程,并梳理健康皮肤微生物组及慢性炎症性疾病(尤其银屑病)相关失调的当前认识。

主要发现

  • 皮肤特异(部位与微环境)、个体特异(卫生、性别、年龄与激素状态)、疾病特异(特应性湿疹、痤疮)及遗传因素均可影响皮肤微生物组,但程度不一且尚未明确。
  • 文章讨论了个体内不同微生物组间交叉对话的可能性与临床相关性,并强调驻留皮肤菌群与免疫系统交互的潜在机制。

临床怎么用

  • 皮肤微生物组特征与疾病及药物反应内型的整合,可能为慢性多系统炎症性疾病的临床管理提供新思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With several million microbes per square centimetre of skin, the task of mapping the physiological cutaneous microbiome is enormous. Indeed, the reliance on bacterial culture to identify cutaneous bacterial communities has led to a systematic underappreciation of cutaneous microbial diversity, potentially limiting our understanding of common inflammatory skin diseases, including psoriasis. However, based heavily on developments in molecular biology and bioinformatics, including next-generation sequencing, the last decade has witnessed a marked increase in our understanding of the extent and composition of the cutaneous microbiome. It is already clear that skin-specific (skin site and skin microenvironment), individual-specific (hygiene, sex, age and hormonal status), disease-specific (atopic eczema, acne) and genetic factors can all influence the cutaneous microbiome, albeit to varying and, as yet, ill-defined extents. OBJECTIVES: To investigate the role of the microbiome in psoriasis and to outline how microbiome studies can be harnessed to provide new insights into disease pathogenesis and treatment selection. METHODS: This review briefly describes the process of 16S ribosomal RNA sequencing and then charts our current understanding of the cutaneous microbiome in health and the alterations (dysbiosis) associated with chronic inflammatory diseases, with particular reference to psoriasis. RESULTS: The possibility and clinical relevance of intraindividual cross-talk between the various microbiomes is discussed and potential mechanisms underpinning the interactions between resident skin flora and the immune system are highlighted. CONCLUSIONS: Ultimately, in the age of personalized medicine, the integration of cutaneous microbiome signatures and comprehensive disease and drug response endotypes will herald a novel approach in the clinical management of chronic multisystem inflammatory diseases.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Langan EA, Griffiths CEM, Solbach W, et al. The role of the microbiome in psoriasis: moving from disease description to treatment selection? Br J Dermatol. 2018. PMID: 29071712. doi:10.1111/bjd.16081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。